vimarsana.com
Home
Live Updates
Clene Reports New Data from the VISIONARY-MS Phase 2 Study in Multiple Sclerosis Demonstrating CNM-Au8® Treatment Improved Brain Neuronal Structural Integrity : vimarsana.com
Clene Reports New Data from the VISIONARY-MS Phase 2 Study in Multiple Sclerosis Demonstrating CNM-Au8® Treatment Improved Brain Neuronal Structural Integrity
MRI results reinforce the clinical neurological improvements previously reportedMRI results showed improved brain neuronal structural integrity, independent of an immunomodulatory effectMRI results... | February 13, 2023
Related Keywords
Salt Lake City
,
Utah
,
United States
,
Maryland
,
Robert Glanzman
,
Kevin Gardner
,
Michael Barnett
,
Ignacio Guerrero Ros
,
David Schull
,
Benjamin Greenberg
,
Linkedin
,
Twitter
,
Americas Committee For Treatment
,
Clene Nanomedicine Inc
,
Russo Partners
,
Nasdaq
,
Clene Inc
,
Securities Exchange
,
Facebook
,
Research In Multiple Sclerosis
,
Mean Difference
,
Cerebral White Matter
,
Cerebral Normal Appearing White Matter
,
Professor Michael Barnett
,
Chief Medical Officer
,
Americas Committee
,
Multiple Sclerosis
,
Clene Nanomedicine
,
Securities Exchange Act
,
Securities Act
,
Annual Report
,
Quarterly Reports
,
Clene Inc Stock Exchange
,
News
,
Information
,
Press Release
,
Ri
,
Results
,
Reinforce
,
The
,
Linical
,
Neurological
,
Improvements
,
Reviously
,
Eportedmri
,
Howed
,
Mproved
,
Rain
,
Neuronal
,
Structural
,
Independent
,
F
,
N
,
Immunomodulatory
,
Ffectmri Clnn Us1856341029
,
vimarsana.com © 2020. All Rights Reserved.